The analytical performance and practicability of the Boehringer Mannheim (BM)/mtaci 91 analysis system have been assessed in a multicentre evaluation, which involved six laboratories from European countries. Analytes commonly used in classical clinical chemistry were tested in a core programme, which mainly followed lhe ECCLS guidelines. In addition, a satellite programme covered other analytes, such as proteins, drugs and urine analytes. In total, the study comprised more than 100 000 data items collected over a three-month period. The evaluation was supported with 'Computer Aided Evaluation' (CAEv) (phenobarbital, phenytoin, theophylline, digoxin) and urinalysis (albumin, /-N-a.cetylglucosaminidase, creatinine, sodium, potassium, chloride). In addition, creatinine kinase MB isoform and fruc- 
Introduction
The Boehringer Mannheim [1] . In addition, the behaviour of the system in different laboratory sections was tested in a satellite programme.
The evaluators ran a much less extensive satellite evaluation in order to maintain an acceptable cost/benefit ratio. In total, the study included more than 100 000 data. Processing and analysis of the large data [2] . The program runs on a standard PC under MS-DOS. It had previously been successfully applied to the multicentre evaluation of the BM/Hitachi 747 analysis system [3] .
Telecommunications were used for the first time in an international multicentre evaluation. Installation of the necessary facilities in the participating laboratories allowed rapid and simple transfer of data to the centre coordinating the study. (7) Prozone check (detection of antigen excess). (8) Linear and four nonlinear modes of calibration, the frequency of which is controlled by the instrument (auto-calibration). ---Measurements of five aliquots of a high-concentration sample (hi"" "hs) are followed by --Measurements of five aliquots of a low-concentration sample (11" "15 [3] .
(continued) figure 12 . 
Within-run imprecision
The results for control and human materials (see table 5) show. that overall the instrument had given a good performance. [12, 13] , it was concluded that the BM/Hitachi 911 analysis system achieved these specifications for nearly all analytes evaluated in the study (table 9) . The proposed quality specifications were not met with the calcium assay (interim specification 1"5, BM/Uitachi 911 1"6%), creatinine assay (specification 2"2, BM/Hitachi 911 2"3%), sodium assay (interim specification 0"7%, BM/ Hitachi 911 1"4%) and the chloride assay (interim specification 1"0%, BM/Hitachi 911 1"7%). However, since the imprecision of the calcium and the creatinine assay were only 0"1 higher than the specifications, the results obtained can be judged acceptable. Owing to the low biological variation of sodium and chloride, the imprecision specifications were set very low: 0"3 for sodium and 0"7% for chloride. Since no available technology is capable of producing such a low imprecision at a reasonable cost, interim specifications with 0"7 and 1"0 were proposed. Even these values are unlikely to be easily achieved with the existing technology.
Analylical range limits
The acceptance criteria tbr linearity of the measuring range were fulfilled for all analytes, except for urinary albumin at concentrations below 25 mg/1. This nonlinearity resulted in an underestimation of about 3 mg/1 albumin at the decision level of 20 mg/1. This is within the range found during the multicentre evaluation tbr the albumin test [14] . In view of the large biological variation of this analyte, this deviation was considered acceptable. During the evaluation, single-point calibration had been used for the C-reactive protein assay. This mode of 
